Indazole-carboxamide compounds as 5-HT4 receptor agonists

Details for Australian Patent Application No. 2005214368 (hide)

Owner Theravance, Inc.

Inventors Turner, S. Derek; Goldblum, Adam A.; Long, Daniel D.; Choi, Seok-Ki; Liu, Jyanwei; Marquess, Daniel; Fatheree, Paul R.; Gendron, Roland

Agent Davies Collison Cave

Pub. Number AU-A-2005214368

PCT Pub. Number WO2005/080389

Priority 60/545,702 18.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

International Classifications

C07D 451/04 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080389 Priority application(s): WO2005/080389

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214369-Sulfur-containing compositions and processes for making same

2005214363-Vectors having both isoforms of betahexosaminidase and uses of the same